Literature DB >> 11339761

Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the MED3631-A/M125I source.

M J Rivard1.   

Abstract

Brachytherapy dosimetry parameters for MED3631-A/M 125I sources have been determined in accordance with the AAPM Task Group No. 43 (TG-43) dosimetry protocol. These data were calculated using the *F8 tally from the MCNP4B2 Monte Carlo radiation transport code with the DLC-189 cross-section libraries. Due to motion of the 125I resin beads and gold-copper markers within the capsule, parameters such as the geometry function, radial dose function, dose rate constant, and anisotropy function were examined with the beads and markers having either "realistic" or "ideal" positions; the realistic position was a weighted combination of "vertical" and "diagonal" capsule orientations. The dose rate constants for the realistic and ideal geometries, lambda99std(realistic) and lambda99std(ideal) were 1.066 and 1.067 cGy h(-1) U(-1), respectively, which were within uncertainties of measured values by Wallace and Fan [Med. Phys. 26, 1925-1931 (1999)] and Li et al. [Med. Phys. 27, 1275-1280 (2000)], 1.06 and 1.067 cGy h(-1) U(-1), respectively. The calculated reference dose rate at r0= 1 and theta0= 90 degrees for the realistic source geometry was 0.7% less than for the ideal source geometry. The anisotropy constants, phian(realistic), for the realistic and ideal geometries were 0.948 and 0.965, respectively. phian(realistic) matched that (0.941) measured by Wallace and Fan, and phian(ideal) was significantly different from that (0.948) calculated by Wierzbicki et al. [Med. Phys. 25, 2197-2199 (1998)] for an ideal MED3631-A/S 125I source.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11339761     DOI: 10.1118/1.1355306

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  6 in total

1.  Dosimetric characterization of the GammaClip™ 169Yb low dose rate permanent implant brachytherapy source for the treatment of nonsmall cell lung cancer postwedge resection.

Authors:  Blake Currier; John J Munro; David C Medich
Journal:  Med Phys       Date:  2013-08       Impact factor: 4.071

2.  A dosimetric uncertainty analysis for photon-emitting brachytherapy sources: report of AAPM Task Group No. 138 and GEC-ESTRO.

Authors:  Larry A DeWerd; Geoffrey S Ibbott; Ali S Meigooni; Michael G Mitch; Mark J Rivard; Kurt E Stump; Bruce R Thomadsen; Jack L M Venselaar
Journal:  Med Phys       Date:  2011-02       Impact factor: 4.071

3.  A Monte Carlo evaluation for effects of probable dimensional uncertainties of low dose rate brachytherapy seeds on dose.

Authors:  Berkay Camgöz; Mehmet N Kumru
Journal:  Rep Pract Oncol Radiother       Date:  2014-07-19

Review 4.  Evaluation of a Proposed Biodegradable 188Re Source for Brachytherapy Application: A Review of Dosimetric Parameters.

Authors:  Abdollah Khorshidi; Marjan Ahmadinejad; S Hamed Hosseini
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

5.  Thermoluminescent and Monte Carlo dosimetry of IR06-103Pd brachytherapy source.

Authors:  Pooneh Saidi; Mahdi Sadeghi; S Hamed Hosseini; Claudio Tenreiro
Journal:  J Appl Clin Med Phys       Date:  2011-11-15       Impact factor: 2.102

6.  A technical evaluation of the Nucletron FIRST system: conformance of a remote afterloading brachytherapy seed implantation system to manufacturer specifications and AAPM Task Group report recommendations.

Authors:  Mark J Rivard; Dee-Ann Radford Evans; Ian Kay
Journal:  J Appl Clin Med Phys       Date:  2005-01-12       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.